November 2013

Cliniminds is India's one of the most prestigious clinical research, health sciences, pharmacovigilance and healthcare education and training company. Cliniminds has over 50 employees and have presence in over 12 cities in India and 3 international locations.

Post: Business Development Manager - Health Sciences Education & Training

For more than 20 years, as Albany Molecular Research Inc. (AMRI), we have provided fully integrated drug discovery, development and manufacturing services – all while adapting to the rapidly changing needs of our customers within the pharmaceutical, biotechnology and related industries.
With locations in the United States, Europe and Asia, AMRI SMARTSOURCING™ offers you a versatile and strategic way of partnering with us that is designed to deliver reduced risk, greater flexibility and a better return on investment. AMRI has successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.

Post: Research Scientist I-Medchem/Chemde - (1507)

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Medical Writer II

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Post: Senior Manager-QA (Biologics) - HC/JC/3166/2013

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Post: Senior Manager-Quality Control (Biologics) - HC/JC/2496/2013

The Department of Biology, University of Copenhagen offers a 2-year post doctoral position in population genetics of potato late blight (Phytophthora infestans). The position starts September 2013 or soon thereafter and is funded through a research grant ("BioMark") from the Danish Environmental Protection Agency (EPA).
The project will provide biological knowledge on population genetics of Potato late blight Phytophthora infestans) in Denmark in order to offer a genetically based risk assessment of the disease. The risk assessment will include fungicide resistance, virulence etc. and will be PCR based. The work will focus on sequence and micro satellite data analyses to develop genetic markers that will detect epidemiological characteristics of the population.

ABOUT AUTHORS:
Ramesh Babu Pedada¹*, Eukondalu Vanka¹, Dr.A.M.S.Sudhakar Babu¹, Prasanna kumar Desu¹, P.Ramaa Bharathi¹, P.Venkateawara.rao^2
1Department of Pharmaceutics, ²Department of Pharmaceutical  Analysis,
A.M.Reddy Memorial College of pharmacy, Narasaraopet, Guntur (Dt), Andhra Pradesh, India.
Rameshbabu.pedada@gmail.com
{ DOWNLOAD AS PDF }

ABSTRACT:
Enhancement of solubility, dissolution rate and bioavailability of drug is a very challenging task in drug development, nearly 40% of the new chemical entities currently being discovered are poorly water soluble drugs. Aqueous solubility of any therapeutically active substance is a key property as it governs dissolution, absorption and thus the in vivo efficacy. Orally administered drugs completely absorb only when they show fair solubility in gastric medium and such drugs shows good bioavailability. The solubility and dissolution properties of drugs play an important role in the process of formulation development. Problem of solubility is a major challenge for formulation scientist which can be solved by different technological approaches during the pharmaceutical product development work. The present review deals in detail about the solubilisation by surfactants, cosolvents, complexation for the improvement of solubility of poorly water soluble drugs.

Dubai based pharma MNC expanding its business in India

Post: Regulatory Affairs Executive